High prevalence of occult hepatitis C virus infection in patients with chronic hepatitis B virus infection

References

1. Bartolomé J., López-Alcorocho J. M., Castillo I., Rodríguez-Iñigo E., Quiroga J. A., Palacios R., Carreño V. 2007; Ultracentrifugation of serum samples allows detection of hepatitis C virus RNA in patients with occult hepatitis C. J Virol 81:7710–7715 [View Article][PubMed]
   [Google Scholar]
2. Bokharaei-Salim F., Keyvani H., Monavari S. H. R., Alavian S. M., Madjd Z., Toosi M. N., Alizadeh A. H. M. 2011; Occult hepatitis C virus infection in Iranian patients with cryptogenic liver disease. J Med Virol 83:989–995 [View Article][PubMed]
   [Google Scholar]
3. Cacciola I., Pollicino T., Squadrito G., Cerenzia G., Orlando M. E., Raimondo G. 1999; Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 341:22–26 [View Article][PubMed]
   [Google Scholar]
4. Castillo I., Pardo M., Bartolomé J., Ortiz-Movilla N., Rodríguez-Iñigo E., de Lucas S., Salas C., Jiménez-Heffernan J. A., Pérez-Mota A. other authors 2004; Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis 189:7–14 [View Article][PubMed]
   [Google Scholar]
5. Castillo I., Rodríguez-Iñigo E., López-Alcorocho J. M., Bartolomé J., Pardo M., Carreño V. 2007; Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection. J Med Virol 79:236–241 [View Article][PubMed]
   [Google Scholar]
6. Castillo I., Bartolomé J., Quiroga J. A., Barril G., Carreño V. 2011; Long-term virological follow up of patients with occult hepatitis C virus infection. Liver Int 31:1519–1524 [View Article][PubMed]
   [Google Scholar]
7. Chen S.-Y., Kao C.-F., Chen C.-M., Shih C.-M., Hsu M.-J., Chao C.-H., Wang S.-H., You L.-R., Lee Y.-H. 2003; Mechanisms for inhibition of hepatitis B virus gene expression and replication by hepatitis C virus core protein. J Biol Chem 278:591–607 [View Article][PubMed]
   [Google Scholar]
8. Chu C. M., Yeh C. T., Liaw Y. F. 1998; Low-level viremia and intracellular expression of hepatitis B surface antigen (HBsAg) in HBsAg carriers with concurrent hepatitis C virus infection. J Clin Microbiol 36:2084–2086[PubMed]
   [Google Scholar]
9. De Marco L., Manzini P., Trevisan M., Gillio-Tos A., Danielle F., Balloco C., Pizzi A., De Filippo E., D’Antico S. other authors 2012; Prevalence and follow-up of occult HCV infection in an Italian population free of clinically detectable infectious liver disease. PLoS ONE 7:e43541 [View Article][PubMed]
   [Google Scholar]
10. Leb V., Stöcher M., Valentine-Thon E., Hölzl G., Kessler H., Stekel H., Berg J. 2004; Fully automated, internally controlled quantification of hepatitis B Virus DNA by real-time PCR by use of the MagNA Pure LC and LightCycler instruments. J Clin Microbiol 42:585–590 [View Article][PubMed]
    [Google Scholar]
11. Mrani S., Chemin I., Menouar K., Guillaud O., Pradat P., Borghi G., Trabaud M. A., Chevallier P., Chevallier M. other authors 2007; Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C. J Med Virol 79:1075–1081 [View Article][PubMed]
    [Google Scholar]
12. Quiroga J. A., Castillo I., Llorente S., Bartolomé J., Barril G., Carreño V. 2009; Identification of serologically silent occult hepatitis C virus infection by detecting immunoglobulin G antibody to a dominant HCV core peptide epitope. J Hepatol 50:256–263 [View Article][PubMed]
    [Google Scholar]
13. Sagnelli E., Pasquale G., Coppola N., Scarano F., Marrocco C., Scolastico C., Santantonio T., Gentile A., Piccinino F. 2004; Influence of chronic coinfection with hepatitis B and C virus on liver histology. Infection 32:144–148 [View Article][PubMed]
    [Google Scholar]
14. Scheuer P. J. 1991; Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 13:372–374 [View Article][PubMed]
    [Google Scholar]
15. Schüttler C. G., Fiedler N., Schmidt K., Repp R., Gerlich W. H., Schaefer S. 2002; Suppression of hepatitis B virus enhancer 1 and 2 by hepatitis C virus core protein. J Hepatol 37:855–862 [View Article][PubMed]
    [Google Scholar]
16. Sheen I. S., Liaw Y. F., Chu C. M., Pao C. C. 1992; Role of hepatitis C virus infection in spontaneous hepatitis B surface antigen clearance during chronic hepatitis B virus infection. J Infect Dis 165:831–834 [View Article][PubMed]
    [Google Scholar]
17. Zarski J. P., Bohn B., Bastie A., Pawlotsky J. M., Baud M., Bost-Bezeaux F., Tran van Nhieu J., Seigneurin J. M., Buffet C., Dhumeaux D. 1998; Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol 28:27–33 [View Article][PubMed]
    [Google Scholar]